StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Non-GAAP Adjusted Selling, General & Administrative by Quarter

Non-GAAP Adjusted Selling, General & Administrative Expense ($M) ($M)

QuarterlyAnnual

BeOne Medicines Non-GAAP Adjusted Selling, General & Administrative: $501M in Q2 2026, up 13.4% from a year earlier. That is the highest of the 15 quarters on record here.

Latest, Q2 2026
501
Period ended Jun 30, 2026
Change on a year earlier
+13.4%
442 in Q2 2025
History
15 quarters
Since Q4 2022
Sources
11
Documents cited below

Where the Q2 2026 figure comes from

“|| Adjusted selling, general and administrative | $ | 500,674 | $ | 441,655 | $ | 972,667 | $ | 837,166”

Source: Form 8-K (filed 2026-08-05) ↗

Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Adjusted Selling, General & Administrative Expense ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026501+13.4%Form 8-K (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026472+19.3%Form 8-K (filed 2026-05-06) ↗
Q4 2025Dec 31, 2025471+8.9%Form 8-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 2025434+14.1%Form 8-K (filed 2025-11-06) ↗
Q2 2025Jun 30, 2025442+21.4%Form 8-K (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025396+6.3%Form 8-K (filed 2025-05-07) ↗
Q4 2024Dec 31, 2024433+19.8%Form 8-K (filed 2025-02-27) ↗
Q3 2024Sep 30, 2024381+23.4%Form 8-K (filed 2024-11-12) ↗
Q2 2024Jun 30, 2024364+9.7%Form 8-K (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024372+31.4%Form 8-K (filed 2024-05-08) ↗
Q4 2023Dec 31, 2023361+31.1%Form 8-K (filed 2024-02-26) ↗
Q3 2023Sep 30, 2023308–Form 8-K (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023332–Form 8-K (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023283–Form 8-K (filed 2024-05-08) ↗
Q4 2022Dec 31, 2022276–Form 8-K (filed 2024-02-26) ↗

Cite this data

StockData. (2026). BeOne Medicines Non-GAAP Adjusted Selling, General & Administrative ($M), quarterly Q4 2022–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-sga-exp

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.